Vineet R. Jindal Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity

RPHM Quotes by TradingView

Vineet R. Jindal is Chief Financial Officer of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 36,600 shares of RPHM, which is worth approximately $61,488. The most recent transaction as insider was on Dec 10, 2021, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.6K
0% 3M change
0% 12M change
Total Value Held $61,488

Vineet R. Jindal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 10 2021
BUY
Grant, award, or other acquisition
-
30,000 Added 45.05%
36,600 Common Stock
Aug 25 2021
BUY
Open market or private purchase
$37,200 $7.44 p/Share
5,000 Added 50.0%
5,000 Common Stock
VRJ

Vineet R. Jindal

Chief Financial Officer
Irvine, CA

Track Institutional and Insider Activities on RPHM

Follow Reneo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

News

Receive news related to Reneo Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPHM